Aldeyra Therapeutics, Inc.ALDX
Price (close)
$1.21
Market cap
$72.7M
P/E
—
Revenue (TTM)
—
Net income
-$23.1M
Dividend yield
—
1-year total return
-75.7%
Net margin
—
Revenue growth
—
Debt / equity
0.00x
What Aldeyra Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$37.6M | -$57.8M | -$62.0M | -$37.5M | -$55.9M | -$33.8M |
| Free cash flow | — | -$42.6M | -$56.7M | -$30.3M | — | — |
More on ALDX.
- Aldeyra Therapeutics, Inc. summary
- Aldeyra Therapeutics, Inc. financial statements
- Aldeyra Therapeutics, Inc. key metrics
- Aldeyra Therapeutics, Inc. health scores and style box
- Aldeyra Therapeutics, Inc. earnings
- Aldeyra Therapeutics, Inc. dividends
- Aldeyra Therapeutics, Inc. valuation
- Aldeyra Therapeutics, Inc. ownership and insiders
- Aldeyra Therapeutics, Inc. peers
Figures from Aldeyra Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.